Josef Messinger

Espoo, 02101, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead.

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead.

Journal: ChemMedChem
Published: November 18, 2024

Correction to: Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.

Correction to: Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.

Journal: Purinergic signalling
Published: June 19, 2024

Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.

Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.

Journal: Purinergic signalling
Published: January 24, 2024

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation.

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation.

Journal: ChemMedChem
Published: January 03, 2023

Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD.

Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD.

Journal: Cell reports
Published: May 19, 2021

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.

Journal: ChemMedChem
Published: January 18, 2021

The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes.

The European Federation for Medicinal Chemistry (EFMC) Best Practice Initiative: Validating Chemical Probes.

Journal: ChemMedChem
Published: August 07, 2020

1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.

1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.

Journal: Bioorganic & medicinal chemistry letters
Published: February 19, 2016

Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors.

Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors.

Journal: PloS one
Published: March 29, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026